202 related articles for article (PubMed ID: 19427229)
1. Male breast cancer.
Ottini L; Palli D; Rizzo S; Federico M; Bazan V; Russo A
Crit Rev Oncol Hematol; 2010 Feb; 73(2):141-55. PubMed ID: 19427229
[TBL] [Abstract][Full Text] [Related]
2. 19. Male breast cancer: aetiology, genetics and clinical management.
Tischkowitz MD; Hodgson SV; Fentiman IS
Int J Clin Pract; 2002 Dec; 56(10):750-4. PubMed ID: 12510948
[TBL] [Abstract][Full Text] [Related]
3. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
[TBL] [Abstract][Full Text] [Related]
4. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer: a special therapeutic problem. Anything new? (Review).
Gennari R; Curigliano G; Jereczek-Fossa BA; Zurrida S; Renne G; Intra M; Galimberti V; Luini A; Orecchia R; Viale G; Goldhrisch A; Veronesi U
Int J Oncol; 2004 Mar; 24(3):663-70. PubMed ID: 14767551
[TBL] [Abstract][Full Text] [Related]
6. Male breast cancer.
Reis LO; Dias FG; Castro MA; Ferreira U
Aging Male; 2011 Jun; 14(2):99-109. PubMed ID: 21204612
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of male breast cancer.
Weiss JR; Moysich KB; Swede H
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):20-6. PubMed ID: 15668471
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.
Loman N; Johannsson O; Bendahl PO; Borg A; Fernö M; Olsson H
Cancer; 1998 Jul; 83(2):310-9. PubMed ID: 9669814
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
11. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
[TBL] [Abstract][Full Text] [Related]
12. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
Cutuli B; Le-Nir CC; Serin D; Kirova Y; Gaci Z; Lemanski C; De Lafontan B; Zoubir M; Maingon P; Mignotte H; de Lara CT; Edeline J; Penault-Llorca F; Romestaing P; Delva C; Comet B; Belkacemi Y
Crit Rev Oncol Hematol; 2010 Mar; 73(3):246-54. PubMed ID: 19442535
[TBL] [Abstract][Full Text] [Related]
13. Male breast cancer--an andrological disease: risk factors and diagnosis.
Krause W
Andrologia; 2004 Dec; 36(6):346-54. PubMed ID: 15541050
[TBL] [Abstract][Full Text] [Related]
14. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
15. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
17. Unilateral male breast masses: cancer risk and their evaluation and management.
Volpe CM; Raffetto JD; Collure DW; Hoover EL; Doerr RJ
Am Surg; 1999 Mar; 65(3):250-3. PubMed ID: 10075303
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study and its prognostic implication in male breast carcinoma.
Mitra D; Manna A; Sikdar SK; Sur PK
J Indian Med Assoc; 2007 Dec; 105(12):681-3, 686. PubMed ID: 18478727
[TBL] [Abstract][Full Text] [Related]
19. Male breast cancer.
Winchester DJ
Semin Surg Oncol; 1996; 12(5):364-9. PubMed ID: 8873325
[TBL] [Abstract][Full Text] [Related]
20. Male breast cancer.
Joseph A; Mokbel K
Int J Fertil Womens Med; 2004; 49(5):198-9. PubMed ID: 15633473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]